Products
Online Inquiry
Our Products Cannot Be Used As Medicines Directly For Personal Use.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
oligosaccharide reducing-end xylanase
Cat No.
EXWM-3839
Description
The enzyme, originally isolated from the bacterium Bacillus halodurans C-125, releases the xylose unit at the reducing end of oligosaccharides ending with the structure β-D-xylopyranosyl-(1→4)-β-D-xylopyranosyl-(1→4)-β-D-xylopyranose, leaving the new reducing end in the α configuration. It is specific for the β anomers of xylooligosaccharides whose degree of polymerization is equal to or greater than 3.The penultimate residue must be β-D-xylopyranose, but replacing either of the flanking residues with glucose merely slows the rate greatly.
Form
Liquid or lyophilized powder
Enzyme Commission Number
CAS No.
879497-03-7
Storage
Store it at +4 ºC for short term. For long term storage, store it at -20 ºC～-80 ºC.
Synonyms
Rex; reducing end xylose-releasing exo-oligoxylanase
Reaction
Hydrolysis of (1→4)-β-D-xylose residues from the reducing end of oligosaccharides
Notes
This item requires custom production and lead time is between 5-9 weeks. We can custom produce according to your specifications.
Download
Download Datasheet"Oligosaccharide reducing-end xylanase" Total Products Page
| Catalog | Product Name | EC No. | CAS No. | Source | Price |
|---|---|---|---|---|---|
| NATE-1515 | Oligosaccharide reducing-end xylanase 8A from Bacillus halodurans, Recombinant | EC 3.2.1.156 | 879497-03-7 | E. coli | Inquiry |
| NATE-1516 | Oligosaccharide reducing-end xylanase 8A from Bifidobacterium adolescentis, Recombinant | EC 3.2.1.156 | 879497-03-7 | E. coli | Inquiry |